MRMD · Marimed Inc.
$0.08
0.00 (-1.51%)
At close · Aug 26
Market Cap
$35.59M
Shares
403.04M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.08
Open$0.09
Day$0.08–0.09
52W close$0.06–0.18
Avg vol 30d527K
Short int22K · 0.0% float · 1.0d
Short vol18%
Last earningsAug 13, 2026
DataJan 2020–Aug 2026
Filing10-Q · Aug 13
Up next
Next earnings call
Nov 12, 2026
Est · unconfirmed
· in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 13, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Neutral
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.64
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+6%
above
Price vs 50-day avg
+24%
above
RSI (14)
66
neutral
MACD trend
Positive
52-week position
19%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+25%
trailing
6-month return
+4%
trailing
YTD return
−10%
this year
Relative strength
−9%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-33% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.01% of float · ▲ +124.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
2 holders — near 3-yr low, contrarian setup
Squeeze score
65
elevated · 0–100
Fundamentals
Revenue growth
+12%
Y/Y
Gross margin
114%
contracting
EPS growth
−33%
Y/Y
Free cash flow
$6.5M
Balance sheet
$91.9M
net debt
Quant / Vol
risk profile
Volatility
96%
annualized · 1-yr
Max drawdown
−65%
past year
ATR
8.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+6%
Bullish
Price vs 50-day avg
+24%
Bullish
RSI (14)
66
Neutral
MACD trend
Positive
Bullish
52-week position
19%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-33% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.01% of float · ▲ +124.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
2 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0
Now $0 · 19%
Range high $0
vs 200-day avg +6%
vs 50-day avg +24%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Non-GAAP Adjusted EBITDA non-GAAP | $7.5M | Six months ended June 30, 2026 | — |
|
|
|||
| Non-GAAP Adjusted EBITDA margin non-GAAP | 9% | Six months ended June 30, 2026 | — |
|
|
|||
| Non-GAAP Gross margin non-GAAP | 40% | Six months ended June 30, 2026 | — |
|
|
|||
| Non-GAAP Net loss non-GAAP | -$5.5M | Six months ended June 30, 2026 | — |
|
|
|||
| Non-GAAP Net income non-GAAP | $2.2M | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MRMD
this stock
Marimed Inc.
|
$35.59M | -9.7% | +11.6% | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$58.22B | +16.9% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$49.94B | +2.3% | — | — | 0.0% |
|
HLN
Haleon plc
|
$44.77B | +0.6% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
2
- % held
- 0.2%
- Net QoQ
- -4.3K sh
- Top holder
- Canton Hathaway, LLC
Held
Float
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MRMD | +23.9% | +25.2% | +3.5% | +34.8% | -9.7% |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | +24.3% | +20.2% | -8.9% | +32.2% | -22.0% |